Here are three things to know.
1. The drug is an anti-viral used for the prevention and treatment of influenza virus infection.
2. The treatment represents a generic version of Genentech’s Tamiflu.
2. Nesher, a subsidiary of Zydus Phramaceuticals USA, will produce the drug at a manufacturing facility in St. Louis.
More articles on supply chain:
Sanofi, Lonza to build $285M biologics facility
4 statistics on 2017 pharma price hikes
Lupin CEO: Border tax would significantly disrupt generic drugmakers’ supply chains
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.